创新医疗: 2025年半年度财务报告

Core Viewpoint - The financial report of Innovation Medical Management Co., Ltd. for the first half of 2025 indicates a decline in both revenue and net profit compared to the same period in 2024, highlighting challenges in operational performance and profitability [5][6]. Financial Performance - Total operating revenue for the first half of 2025 was CNY 401,530,071.25, a decrease from CNY 408,040,808.16 in the same period of 2024, representing a decline of approximately 1.25% [5]. - Total operating costs were CNY 414,194,757.65, slightly down from CNY 417,087,062.79, resulting in a marginal reduction of about 0.68% [5]. - The operating loss for the period was CNY 8,594,054.71, an improvement from a loss of CNY 14,614,226.16 in the previous year [5]. - The net loss for the first half of 2025 was CNY 11,191,930.35, compared to a net loss of CNY 15,885,150.73 in the same period of 2024, indicating a reduction in losses [5][6]. Assets and Liabilities - Total assets at the end of the reporting period were CNY 2,154,289,877.85, down from CNY 2,203,947,708.41 at the beginning of the year [2][3]. - Current assets totaled CNY 574,411,295.16, a decrease from CNY 598,852,540.99 [2]. - Total liabilities decreased to CNY 388,382,966.52 from CNY 426,848,866.73, reflecting a reduction in both current and non-current liabilities [3][4]. Cash Flow - Net cash flow from operating activities was CNY 83,722,284.41, a significant improvement from a negative cash flow of CNY -3,377,424.14 in the previous year [6][7]. - Cash and cash equivalents at the end of the period increased to CNY 229,025,347.33 from CNY 195,985,297.72 at the beginning of the year [7]. Equity - Total equity attributable to shareholders was CNY 1,764,836,788.89, slightly down from CNY 1,776,198,085.17 at the beginning of the year [3][4]. - The company reported an accumulated deficit of CNY -1,409,553,038.17, which has increased from CNY -1,398,191,741.89 [3][4].